Aberegg Scott K
Jordan Valley Medical Center, West Jordan, UT.
Chest. 2016 Mar;149(3):846-55. doi: 10.1016/j.chest.2015.12.001. Epub 2015 Dec 15.
Serum ionized calcium (iCa) is often measured in patients admitted to ICUs, and at least half of these patients will have values outside the reference range during their ICU stay. The vast majority of these patients do not have an underlying disease of calcium homeostasis. This Contemporary Review discusses the rationale for measurement of iCa and whether available data support its measurement and correction. It is determined that while measurement of serum iCa is commonplace and attempted correction is popular, available evidence and logical analysis do not wholly support these practices. Abnormal values of iCa are likely a marker of disease severity in critical illness and most often normalize spontaneously with resolution of the primary disease process. Alternatively, low iCa levels in critical illness may be protective and attempted correction of low levels may be harmful. Dramatic curtailment of iCa measurement and calcium administration in several studies was not associated with worsening outcomes. The absence of high-quality data to guide practice allows for a spectrum of approaches to the measurement and treatment of iCa, but these approaches should be guided by basic principles of rational clinical decision-making. Widespread, protocolized measurement and administration with the simple goal of normalizing values in the name of "euboxia" should be discouraged.
重症监护病房(ICU)收治的患者常检测血清离子钙(iCa),且至少半数患者在ICU住院期间其iCa值会超出参考范围。这些患者绝大多数并无钙稳态的基础疾病。本篇当代综述讨论了检测iCa的理论依据,以及现有数据是否支持其检测和校正。研究确定,虽然血清iCa检测很常见,且尝试进行校正也很普遍,但现有证据和逻辑分析并不完全支持这些做法。iCa异常值可能是危重病严重程度的一个指标,且大多会随着原发疾病进程的缓解而自发恢复正常。另外,危重病时低iCa水平可能具有保护作用,试图校正低水平可能有害。多项研究大幅减少iCa检测和钙给药,但并未导致预后恶化。缺乏高质量数据来指导实践,使得在iCa检测和治疗方面有多种方法,但这些方法应以合理临床决策的基本原则为指导。不应鼓励以“纠正低钙血症”为简单目标、广泛且按方案进行的检测和给药。